Literature DB >> 17805798

Preparation and properties of an apoprotein derivative of human serum beta-lipoprotein.

A M Gotto1, R I Levy, D S Fredrickson.   

Abstract

The aim of this study was to develop a convenient method for the preparation and study of a soluble delipidated form of human serum beta-lipoprotein. This was achieved by succinylation and delipidation with ether-ethanol (3ratio1). The succinylated apoprotein was soluble in either 0.13 M Tris-HCl buffer, pH 8.2 (for beta-lipoprotein prepared by ultracentrifugation) or in the same Tris buffer to which 5 mM sodium decyl sulfate was added (for heparin-Mn precipitated beta-lipoprotein). The immunological activity of beta-lipoprotein or its apoprotein were markedly altered by succinylation. Whereas the succinylated beta-lipoprotein appeared as one peak in the analytical ultracentrifuge, the succinylated apoprotein appeared as two. Under the electron microscope beta-lipoprotein and succinylated beta-lipoprotein were indistinguishable, appearing as uniform preparations of spherical particles 215 to 220 A in diamater.

Entities:  

Year:  1968        PMID: 17805798     DOI: 10.1007/BF02530887

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  13 in total

1.  Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer.

Authors:  R S LEES; F T HATCH
Journal:  J Lab Clin Med       Date:  1963-03

2.  The proteolysis of human serum beta-lipoproteins.

Authors:  L J BANASZAK; H J McDONALD
Journal:  Biochemistry       Date:  1962-03       Impact factor: 3.162

3.  Separation and characterization of the protein moiety of human alpha1-lipoprotein.

Authors:  A SCANU; L A LEWIS; F M BUMPUS
Journal:  Arch Biochem Biophys       Date:  1958-04       Impact factor: 4.013

4.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Human serum beta-lipoprotein: preparation and properties of a delipidated, soluble derivative.

Authors:  A M Gotto; R I Levy; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1968-04-19       Impact factor: 3.575

7.  The nature of pre beta (very low density) lipoproteins.

Authors:  R I Levy; R S Lees; D S Fredrickson
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

8.  Studies on human serum beta-1-lipoprotein. II. Chemical modifications.

Authors:  S Margolis; R G Langdon
Journal:  J Biol Chem       Date:  1966-01-25       Impact factor: 5.157

9.  The protein moiety of human serum beta-lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochem Biophys Res Commun       Date:  1967-09-27       Impact factor: 3.575

10.  Properties of human serum low density lipoproteins after modification by succinic anhydride.

Authors:  A Scanu; H Pollard; W Reader
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

View more
  4 in total

1.  A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein.

Authors:  W R Fisher; M G Hammond; M C Mengel; G L Warmke
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

Review 2.  Suppressor lipid-protein complexes of normal human serum.

Authors:  R L Wolf
Journal:  Surv Immunol Res       Date:  1982

3.  A comparaive study of the effects of chemical modification on the immunochemical and optical properties of human plasma low-density lipoprotein(s) and apoproteins.

Authors:  A M Gotto; R I Levy; S E Lux; M E Birnbaumer; D S Fredrickson
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

4.  Recent studies on the structure of human serum low-and high-density lipoproteins.

Authors:  A M Gotto
Journal:  Proc Natl Acad Sci U S A       Date:  1969-11       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.